The QualityStocks Daily Friday, March 27th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (TOPS) +193.13%

StockMarketWatch (BKYI) +94.41%

MarketClub Analysis (EDTX) +49.78%

The QualityStocks Daily Stock List

AdaptHealth Corp. (AHCOW)

All Penny Stocks, OTC Markets, Market Chameleon, InvestingNote, NasdaqTrader, Wallet Investor, Stock Target Advisor, EOD Data, BioPortfolio, Wallmine, Seeking Alpha, wallstreet-online, last10k, Global Banking and Finance, PredictWallStreet, Street Insider, Dividend Investor and Morningstar reported previously on AdaptHealth Corp. (AHCOW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AdaptHealth Corp. is the third largest home medical equipment (HME) provider in the USA. The Company provides a suite of medical products and solutions for rental and sale designed to help patients manage chronic conditions in the home, adapt to life and thrive. AdaptHealth services beneficiaries of Medicare, Medicaid and commercial insurance payors. The Company serves patients through its network of 187 locations. AdaptHealth is based in Plymouth Meeting, Pennsylvania.

AdaptHealth’s product and services offerings include sleep therapy equipment (CPAP and BiPAP machines and supplies), respiratory equipment (including oxygen, invasive and non-invasive ventilation), mobility equipment, wheelchairs, walkers, and hospital beds. Furthermore, the Company provides custom bracing services, hospice-focused HME services, wound therapy, as well as nutritional HME services.

AdaptHealth partners with a broad and highly-diversified network of referral sources. This includes acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. Greater than 800k patients are served annually by the Company. In addition, 7k orders are processed each day and AdaptHealth has greater than 800 commercial insurance contracts.

AdaptHealth announced in November 2019 that it entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation. Currently, PCS provides wound care supplies, ostomy supplies, urological supplies, incontinence supplies, diabetic care supplies, and breast pumps directly to patients across the United States. Following the acquisition of PCS in January 2020, AdaptHealth services more than 1.4 million patients annually in all 50 States.

This month, AdaptHealth announced that it acquired Healthline Medical Equipment, Inc. Healthline is a Texas-based provider of home medical equipment. AdaptHealth also closed its earlier announced acquisition of Advanced Home Care’s home medical equipment business. Healthline is a foremost provider of home medical equipment to patients through its 13 branch locations across the greater Fort Worth and Austin areas. Healthline will continue to operate under its current name and leadership team.

Moreover, AdaptHealth announced the completion of the earlier announced acquisition of Advanced Home Care, Inc. Advanced operates 23 branch locations in Georgia, North Carolina, South Carolina, Tennessee and Virginia. The HME management team of Advanced Home Care, including Chief Executive Officer, Mr. Joel Mills, have joined AdaptHealth in connection with this acquisition.

AdaptHealth Corp. (AHCOW), closed Friday's trading session at $4.20, up 24.6291%, on 8,750 volume with 11 trades. The average volume for the last 3 months is 65,454 and the stock's 52-week low/high is $0.76999998/$5.1550002.

chart

BioXyTran, Inc. (BIXT)

Wallet Investor, Born2Invest, InvestorsHub, Wall Street Analyzer, last10k, Financial Buzz, Proactive Investors, Investors Hangout, Seeking Alpha, TradingView, Stockwatch, Barchart and Simply Wall St reported beforehand on BioXyTran, Inc. (BIXT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioXyTran, Inc. concentrates on developing treatments for stroke and Ischemia. An early stage pharmaceutical company, it focuses on the development, manufacture, and commercialization of different therapeutic drugs to address hypoxia in humans. The Company’s lead pharmaceutical drug candidate is BXT-25. OTCQB-listed, BioXyTran is headquartered in Newton, Massachusetts.

BioXyTran has its BXT-25 and BXT-252. The design of both drugs are to oxygenate ischemic (reduced blood flow) regions of the body and could provide sufferers valuable aid. BXT-25’s co-polymer proprietary chemical structure acts as the principal carrier of oxygen, instead of the red blood cells that are blocked by the clot.

BXT-25 construct significantly lessens methemoglobin formation and nitric oxide scavenging that may contribute to an assortment of disorders. This includes renal failure, vasoconstriction, hypertension, myocardial infarction, and also related toxicity issues.

Additionally, BXT-25’s small size, around 1/5,000th that of a red blood cell, enables it to perfuse constricted, ischemic capillaries that are inaccessible to red blood cells because of clots or other obstructions.

BXT-25 is founded on a new molecule designed to reverse hypoxia in the brain. Hypoxic brain injuries such as ischemic strokes, could be treated with BXT-25 via an intravenous injection that quickly allows the drug molecule to travel to the lungs and bind with the oxygen molecules. From the lungs the molecule mimics a red blood cell traveling to the brain. Since the molecule is 5,000 times smaller than red blood cells, it can penetrate the clot and deliver the oxygen to the critical areas in the brain blocked by the clot.

In testing, BXT-25 will undergo evaluation as a resuscitative agent to treat strokes, especially during the all-critical first hour following a stroke. Furthermore, the product will undergo evaluation for its efficacy in treating other brain trauma issues.

The design of BioXyTran’s BXT-252 is to treat chronic wounds resulting from ischemia caused by occlusion of capillaries. BXT-252 has the same modality and physical properties as BXT-25. However, its proprietary co-polymer can improve the healing of pressure and arterial ulcers.

Last month, BioXyTran announced its intention to explore partnering with global drug companies looking to treat end stage Wuhan Coronavirus patients that have Acute Respiratory Distress Syndrome (ARDS).

Mr. David Platt, BioXyTran Chief Executive Officer, said, “This could be a major advancement in the treatment of end stage patients infected with the Wuhan Coronavirus. In situations like this pandemic, where resources are stretched to their limits, we are looking to develop a common sense solution to improve the mortality rate of this disease right away. Vaccines could be the answer, but they take time. We believe that potential partners will recognize that we have an immediate solution to treat acute patients with BXT-25. Even if an acute patient beats the disease down to a zero viral load they could still die from the ARDS. To fight the disease on another front, we also have the opportunity to upgrade the MDX Viewer to enable remote monitoring.”

This week, BioXyTran announced that it signed an exclusive international licensing agreement with Dr. David Platt for the clinical development and further commercialization of a galectin inhibitor that could potentially treat COVID-19. A presentation of this technology will soon be available. With this agreement, the Company will pay a $5,000 down payment on the licensing fee to Dr. Platt by April 20, 2020. Future milestone payments of up to $4.0 million are due after; the first sample of GMP material, enrollment of the first patient in a Phase 1 trial, and an NDA approval in the U.S. Royalties will range from 15 – 25 percent based on the amount of royalties received.

BioXyTran, Inc. (BIXT), closed Friday's trading session at $0.335, off by 1.4706%, on 61,746 volume with 41 trades. The average volume for the last 3 months is 62,147 and the stock's 52-week low/high is $0.136099994/$1.95000004.

chart
n

Guardion Health Sciences, Inc. (GHSI)

Stocktwits, Nasdaq News Feed, OTC Markets, Investors Observer, Stockhouse, Morningstar, TradingView, Stockopedia, last10k, Market Chameleon, DBT news, GlobeNewswire, StockInvest.us, Investing.com, InvestorsHub, Barchart, Newsheater, Stock News, Simply Wall St, YCharts, The Winnex, Seeking Alpha and Nasdaq reported earlier on Guardion Health Sciences, Inc. (GHSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Guardion Health Sciences, Inc. is an ocular health sciences company based in San Diego, California. It, among other things, develops, formulates, manufactures and distributes condition-specific medical foods supported by evidence-based protocols. The Company also provides ocular testing. Guardion Health Sciences’ initial medical food product, Lumega-Z, addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (AMD) and a significant component of functional vision performance. The Company is at the vanguard of early detection, intervention and monitoring of manifold eye diseases.

In addition, Guardion has developed a proprietary medical device, the MapcatSF®. It accurately measures the macular pigment density, thus providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment. The Mapcat is the most repeatable and accurate measuring technology for the MPOD (macular pigment optical density). Mapcat is protected by patents in the USA and Europe.

The above-mentioned Lumega-Z is the only micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. This inventive delivery platform ensures the highest level of absorption and also rapid patient response to treatment.

The Company also has its VectorVision. This is the most broadly used and respected clinical contrast sensitivity test. Next generation VectorVision products have two patents protecting proprietary methodologies for the standardization of vision testing.

Furthermore, Guardion Health Sciences also has its GlaucoCetin as part of its portfolio. GlaucoCetin is the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.

In February, Guardion Health Sciences announced the development of an innovative proprietary formulation to provide immuno-support and anti-inflammatory benefits targeting the upper respiratory tract. Guardion’s efforts are being led by its recently acquired NutriGuard business line. NutriGuard formulates high-quality, scientifically-credible, condition-specific nutraceuticals designed to supplement consumers’ diets and assist in the prevention and management of a variety of diseases and conditions.

Additionally, in February, Guardion Health Sciences announced that Ho Wah Genting Berhad (HWGB) chose Guardion to develop an immune- supportive formula for their consumer base. HWGB has contracted Guardion and its recently acquired subsidiary NutriGuard to develop a proprietary formula to meet the demands of their customers for an immune-supportive product. HWGB is a Malaysian company listed on the Malaysian Stock Exchange (Industrial Products sector).

Guardion Health Sciences, Inc. (GHSI), closed Friday's trading session at $0.45, up 2.3192%, on 4,638,785 volume with 8,654 trades. The average volume for the last 3 months is 11,064,203 and the stock's 52-week low/high is $0.165000006/$4.00.

chart

Orbit International Corp. (ORBT)

Zacks, Stocktwits, Street Insider, TipRanks, Stockwatch, GlobeNewswire, Morningstar, Nasdaq, OTC Markets, Market Screener, Stockopedia, GuruFocus, CSI Market, TMXmoney, Stockhouse, Seeking Alpha, YCharts, Dividend.com, Simply Wall St, Businesswire, Proactive Investors, Dividend Investor, ETF Channel, Barchart and MarketWatch reported earlier on Orbit International Corp. (ORBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Orbit International Corp. is the parent company of the Orbit Electronics Group and the Orbit Power Group. Since 1957, Orbit companies design and manufacture subsystems and major components for prime contractors, government procurement agencies (foreign and domestic), and research and development (R&D) laboratories globally. The Company also has its Tulip Development Laboratory and Behlman Electronics subsidiary (Orbit Power Group). Orbit International has its corporate office in Hauppauge, New York.

Regarding the Orbit Electronics Group, through delivering pioneering mission-critical hardware with extreme environmental and operational survivability, components in the Orbit Electronics Group have become trusted suppliers of choice for military, government and industrial programs that impose stringent standards for quality and high reliability, where downtime is not an option. Orbit Instrument designs and manufactures customized electronic subsystems and major components for military aircraft, shipboard, handheld and ground-based programs. Orbit Instrument also designs hardware to support severe non-military applications. Orbit Instrument has built, qualified and supported several programs. These include Console Intercommunications Units (CIUs), Command Display Units (CDUs), Digital Transponder (IFF) Units, Secure Voice Systems (SVS), and Global Positioning Systems (GPS) Controller Units that are all current industry standards for harsh terrain battlefield applications.

Tulip Development Laboratory designs and manufactures full military and ruggedized computer peripheral products. These include custom integrated keyboards, illuminated data entry devices, as well as display solutions. Orbit International’s Behlman Electronics subsidiary manufactures and sells custom and off-the-shelf power units, AC power sources, frequency converters and uninterruptible power supplies, and also the electronic products for measurement and display.

In February, Orbit International announced that its Electronics Group (OEG) received a purchase order from a major prime contractor for roughly $2,300,000, for keyboards used on a major military aviation program. The expectation is that deliveries under the contract will begin in Q4 of 2020 and continue through Q1 of 2022.

Mr. Mitchell Binder, President and Chief Executive Officer of Orbit International said, “In December 2019, we reported that we received a significant award for displays used on a military aviation program. This award completes the suite of equipment that we provide for the same aviation program, which brings the total orders for this equipment to over $4,000,000. This follow-on multi-year award will lay a strong foundation to the delivery schedules for our OEG beginning in the fourth quarter of 2020 and extending through the end of 2022.”

Orbit International Corp. (ORBT), closed Friday's trading session at $3.60, off by 1.3726%, on 1,210 volume with 5 trades. The average volume for the last 3 months is 2,445 and the stock's 52-week low/high is $3.41000008/$6.23999977.

chart

ReNeuron Group plc (RNUGF)

Zacks, Future Medicine, Whale Wisdom, Wallmine, Morningstar, StockInvest.us, AnalystRatings, InvestorsHub, TipRanks, Barchart, MacroTrends, GuruFocus, dividata, YCharts, Investors Hangout, Seeking Alpha, Macroaxis, Trading View and Wallet Investor reported beforehand on ReNeuron Group plc (RNUGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ReNeuron Group plc is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. The Company has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug treatments. ReNeuron Group’s headquarters and laboratories are in Pencoed, the United Kingdom (UK). The Company lists on the OTC Markets.

ReNeuron’s therapeutic candidates are based around two core stem cell assets. One is its human retinal progenitor cell line (hRPC). The other is its CTX neural cell line. Its CTX-derived exosome candidate is undergoing development as a novel vector for delivering third party biological drugs.

Currently, ReNeuron’s hRPC cell therapy candidate is undergoing evaluation in a continuing Phase I/IIa clinical trial in the U.S. in subjects with a blindness-causing inherited retinal disease, retinitis pigmentosa (RP). The open-label dose escalation study is being undertaken at two sites to evaluate the safety, tolerability, and preliminary efficacy in subjects with advanced RP - the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts and the Retinal Research Institute in Phoenix, Arizona.

Also, ReNeuron is considering expanding testing of its hRPC cell therapy candidate into subjects with other retinal disorders, including cone-rod dystrophy (CRD). The Company’s chief strategy is to gain clinical validation for its cell therapy programs via well-designed clinical trials in well-regulated territories. It ultimately expects to achieve value for its technologies and therapeutic programs through out-license to commercial development partners at suitable points in their development.

ReNeuron has partnered with Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. This partnership is for the development, manufacture and commercialization of its hRPC and CTX platforms in China.

Last month, ReNeuron Group announced positive long-term data from the continuing Phase 1/2a clinical trial of its hRPC stem cell therapy candidate in retinitis pigmentosa (RP). The Company plans to expand the ongoing study. RP is a group of hereditary diseases of the eye that lead to progressive loss of sight and blindness.

Olav Hellebø, Chief Executive Officer of ReNeuron Group, said, "We remain greatly encouraged by the data from the Phase 1/2a clinical study of our hRPC cell therapy candidate in patients with RP. The longer-term follow-up data are particularly noteworthy, demonstrating that the therapy appears to maintain its beneficial effects out to at least one year post-treatment."

ReNeuron Group plc (RNUGF), closed Friday's trading session at $1.32, even for the day, on 189 volume. The average volume for the last 3 months is 435 and the stock's 52-week low/high is $0.949999988/$4.42999982.

chart

Torque Esports Corp. (MLLLF)

Investing News, Penny Stock Hub, Speedway Digest, Capital10X, Macroaxis, Morningstar, Financial Buzz, Nasdaq, InvestorsHub, GuruFocus, Barchart, Frankly Media, Stockhouse and News Break reported earlier on Torque Esports Corp. (MLLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Torque Esports Corp. recently restructured its business and leadership team. The Company now focuses exclusively on two areas – esports racing and esports data provision. Torque has publishing, IP (Intellectual Property), content, and data expertise in its portfolio, combined with a new Board and Management team. Torque Esports is based in Toronto, Ontario. The Company previously went by the name Millennial Esports Corp. It changed its name to Torque Esports Corp. in October of 2019. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Torque’s aim is to revolutionize esports racing and the racing gaming genre via its industry-leading gaming studio Eden Games ( Lyon, France ). Eden Games focuses on mobile racing games and its unique motorsport IP. This includes World's Fastest Gamer (created and managed by wholly-owned subsidiary IDEAS+CARS, Silverstone UK). Moreover, with simulator company AiS recently added – Torque Esports offers gamers everything from Free to Play mobile games to the highest end simulators.

Stream Hatchet is a Barcelona, Spain -based wholly-owned subsidiary of Torque Esports. Building on the leading position of Stream Hatchet, Torque additionally provides strong esports data and management information to brands, sponsors, as well as industry leaders. This data enables the esports industry to monetize the large number of participants in the gaming and esports space.

Torque Esports, Frankly, Inc. (TLK.V) (OTCQX:FRNKF), and WinView, Inc. announced in November of 2019 that the three companies agreed to combine to create an integrated news, gaming, sports and esports platform. The combined enterprise is called Engine Media Holdings, Inc. ("ENGINE"), [Esports, News, Gaming, Interactive Network, Engagement].

This week, Torque Esports announced that following fast in the wheeltracks of the pioneering All-Star Esports Battle, the Company's “The-Race.com/youtube” is creating a real treat for motorsport fans by launching the Legends Trophy. The Legends Trophy will pit drivers aged 40 and over against one another in identical cars as a prelude to this Saturday's third round of the All-Star Esports Battle.

The format will be simple; qualifying will decide the starting order for the esports race conducted on the rFactor 2 racing platform. IndyCar champions, Le Mans 24 Hours winners and Grand Prix racers fill the list. Two-time Formula One World Champion Emerson Fittipaldi and three-time Indy 500 winners Helio Castroneves and Dario Franchitti are among the first to join the event.

Torque Esports Corp. (MLLLF), closed Friday's trading session at $0.4346, up 8.65%, on 25,364 volume with 15 trades. The average volume for the last 3 months is 43,631 and the stock's 52-week low/high is $0.305999994/$6.53474998.

chart

VanadiumCorp Resource, Inc. (APAFF)

Speculating Stocks, Metals Channel, OTC Markets, Junior Mining Network, Morningstar, AA Stocks, Stockwatch, Seeking Alpha, Wallet Investor, Dividend Investor, TradingView, InvestorsHub, Dividend.com, Ceo.ca, Vanadiumprice.com, Market Screener, GuruFocus and Stockhouse reported previously on VanadiumCorp Resource, Inc. (APAFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

VanadiumCorp Resource, Inc. is developing an integrated supply chain enabling scalable, safe, sustainable, low cost, long duration energy storage solutions for the clean energy future. It is developing vanadium redox flow battery technology under its XRG® brand, a wholly owned vanadium resource base in the Province of Quebec, and jointly owned process technology that recovers vanadium sustainably and efficiently. In addition, VanadiumCorp Resource holds a strategic vanadium-titanium-iron bearing resource base in Quebec.

The Company previously went by the name PacificOre Mining Corp. It changed its name to VanadiumCorp Resource, Inc. in November of 2013. VanadiumCorp Resource has its head office in Vancouver, British Columbia and the Company lists on the OTC Markets.

A mining and technology company, VanadiumCorp Resource’s vision is to become the primary producer of vanadium and specialty metals. Its growth strategy centers on the development of industry leading resources and process technology located in Canada.

The Company has developed a new technology to produce reusable vanadium electrolyte directly and sustainably from virtually any source for perpetual use in vanadium batteries. The technology was jointly developed with Electrochem Technologies and Materials, Inc. “VEPT” eliminates the carbon footprint and high cost associated with worldwide vanadium supply.

In November 2019, VanadiumCorp Resource announced it created a wholly owned subsidiary of VanadiumCorp Resource, Inc. centered on next generation vanadium redox flow battery "VRFB" development in Germany called VanadiumCorp GmbH. VanadiumCorp GmbH introduces XRG® as next generation energy storage technology powered by its own supply chain. Components are manufactured sustainably. Moreover, they are 100 percent reusable and recyclable.

Last week, VanadiumCorp Resource announced that it's wholly owned subsidiary in Germany , VanadiumCorp GmbH signed an order and contract for a vanadium redox flow battery system (VRFB) and a Memorandum of Understanding (MOU) with Ecosource NV a Cordeel Group NV company. Both companies plan to jointly manufacture VRFBs. Furthermore, they share a vision to develop integrated clean energy solutions.

VanadiumCorp Resource, Inc. (APAFF), closed Friday's trading session at $0.031, off by 3.125%, on 21,000 volume with 2 trades. The average volume for the last 3 months is 49,708 and the stock's 52-week low/high is $0.024499999/$0.100000001.

chart

TOP Ships, Inc. (TOPS)

Zacks, Stocktwits, StockInvest.us, Micro Small Cap, Market Screener, US Post News, Stockhouse, GlobeNewswire, Stock Street News, TMXmoney, MacroTrends, Stockopedia, 4-Traders, Wallet Investor, TradingView, Simply Wall St, and Investing.com reported previously on TOP Ships, Inc. (TOPS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

TOP Ships, Inc. is an international owner and operator of modern, fuel efficient “ECO” tanker vessels. Currently, the Company is focusing on the transportation of crude oil and petroleum products. Its business strategy is to grow its fleet via acquisitions of newbuilding, resale or second-hand vessels of top-quality ECO design. Incorporated in the Republic of The Marshall Islands, TOP Ships has its headquarters in Marousi, Greece. In addition, the Company has a London and Monaco office.

TOP Ships’ Management Team consists of executives with broad experience in managing and operating large and diversified fleets of vessels, and with strong ties to several national, regional and international oil companies, charterers and traders. TOP Ships’ Management Team has 94 years of combined shipping experience.

The Company has a high specification ECO design fleet. All vessels are fitted with Ballast Water Treatment Systems and part of the fleet is fitted with Scrubbers.

In September, TOP Ships announced its unaudited financial results for the six months ended June 30, 2019. Highlights for the first half of 2019 include Total Revenues increasing by 51 percent to $29.8 million for the six months ended June 30, 2019 versus $19.7 million for the same period in 2018. Net Loss decreased by 91 percent to ($0.6) million for the six months ended June 30, 2019 versus a Net Loss of ($6.6) million for the same period in 2018.

Evangelos Pistiolis, President, Chief Executive Officer, and Director of TOP Ships, said, “During the first half of the year we further grew our fleet after we took delivery of 4 high specification vessels from Hyundai South Korea: 2 MR Product tankers and 2 Suezmax Crude carriers, 3 of the 4 vessels are scrubber fitted and all entered into time charter employment with high quality counterparties. The newly delivered vessels which were delivered during Q1 and Q2 have already started contributing positively to our financial results. We expect the full operating contribution for these vessels to occur from the second half of the year onwards.”

TOP Ships, Inc. (TOPS), closed Friday's trading session at $0.2345, up 193.125%, on 360,143,599 volume with 212,850 trades. The average volume for the last 3 months is 3,228,264 and the stock's 52-week low/high is $0.078000001/$16.7999992.

chart

Horizons Holdings International, Corp. (HZHI)

All Penny Stocks, Stock Scores, All Stocks Today, EquityNet.com, OTC Markets, TipRanks, Market Wire News, Stockhouse, MarketWatch, PRWeb, InvestorsHub, Morningstar, Dividend.com, GuruFocus, Seeking Alpha, TradingView, Wallet Investor, Dividend Investor, Stockwatch, Market Screener, and PR Newswire reported earlier on Horizons Holdings International, Corp. (HZHI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Horizons Holdings International, Corp. operates as a holding, development and investment company. Its purpose is to enable the acquisition of existing companies and provide additional capital and expertise to boost revenue and profitability of the acquired companies. The Company previously went by the name Horizon Health International Corp. It changed its name to Horizons Holdings International, Corp. in April of 2015. The Company lists on the OTC Markets and is headquartered in Las Vegas, Nevada.

Horizons Holdings International works to maintain an inventory of premier investment opportunities. At present, its emphasis is on the development of its wholly owned subsidiary, Pai-Tech. Pai-Tech has developed a brand-new Bot Operating System Standard (B.O.S.S.). It provides a digital workforce of intelligent and intuitive bots. PAI-BOSS provides a distributed operating system powered by PAI-BOTS. These run advanced AI (Artificial Intelligence) algorithms and offer real-time, autonomous, and also distributed solutions.

Pai’s intelligent bots are able to work in any sector and industry. They provide businesses increased levels of cybersecurity and save companies valuable time and money through decreasing workforce costs, avoiding human errors, increasing the quality of work and enabling data to be read in real-time. Furthermore, Pai’s system is a 24/7 operation, is quantum safe, offers customizable scalable solutions, and has a short payback (ROI) period.

In September, Horizons Holdings International confirmed that its subsidiary, Pai-Tech Artificial Intelligence Ltd., signed an OEM (original equipment manufacturer) distribution agreement with Real Time ltd. to develop and distribute products based on PAI's Bot Operating System Standard (PAI-BOSS). Real Time has already developed a distributed and automated solution for the HR field, HR-BOT. It has been installed in the Israeli government and is going to be sold internationally to enterprise corporations and governments.

Pai-Tech Artificial Intelligence has developed a portfolio of Intellectual Property (IP) and has filed a number of patents to the USPTO (United States Patent and Trademark Office). Pai-Tech makes computers smarter via the power of intelligent bots. The company is pioneering computer software with the development of the world's first Bot Operating System Standard (B.O.S.S.).

Earlier in October, Horizons Holdings International disclosed that its subsidiary, Pai-Tech Artificial Intelligence, co-led the technical development with The Floor for their proprietary Idea Generation Engine called the Discovery platform. The Discovery platform was developed benefiting from Pai-Tech's distributed Operating System (PAI-BOSS).

PAI-BOSS provides the ability to distribute data for better security, distribute workload for better performance, and provides a distributed network architecture to ensure data isolation and protection for each user. The Discovery platform is one of The Floor's proprietary tools for empowering tier-1 banks throughout their digital transformation. The Floor's exclusive ecosystem of Banking Partners has benefited from faster technology adoption and access to market-leading solutions.

Horizons Holdings International, Corp. (HZHI), closed Friday's trading session at $0.15, up 150.00%, on 100 volume with 1 trade. The average volume for the last 3 months is 11,473 and the stock's 52-week low/high is $0.029999999/$2.45000004.

chart

Adynxx, Inc. (ADYX)

TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.

The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.

Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.

The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.

Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.

Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.

For Q2 of 2019, Adynxx reported a Net Loss of $4.7 million, versus a Net Loss of $1.4 million for the same period in 2018. Research and development expenses were $1.9 million in Q2 of 2019, versus $0.6 million for the same period in 2018. This increase was mainly because of $0.7 million in connection with start-up activities related to Adynxx's planned Phase 2 ADYX-005 total knee arthroplasty and Phase 2 ADYX-006 mastectomy clinical trials and $0.7 million related to the initiation of drug supply manufacturing with Avecia, partially offset by a decrease in salaries and benefits from the resignation of an employee and other minor cost changes.

Adynxx, Inc. (ADYX), closed Friday's trading session at $0.37, off by 17.7778%, on 4,451 volume with 4 trades. The average volume for the last 3 months is 1,890 and the stock's 52-week low/high is $0.310099989/$18.4955997.

chart

Minfocus Exploration Corp. (MNNFF)

Trade Ideas, OTC Markets, Market Screener, Wallet Investor, Dividend Investor, Barchart, Stockhouse, MarketWatch, and GuruFocus reported earlier on Minfocus Exploration Corp. (MNNFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

An exploration stage company, Minfocus Exploration Corp. acquires, explores for, and develops base and precious metal mineral properties in Canada. The Company focuses on the advancement of a portfolio of Canadian zinc projects in British Columbia and Newfoundland. In addition, it has a Platinum Group Element (PGE) rich nickel project in northwestern Ontario. Incorporated in 1994, Minfocus Exploration has its corporate headquarters in Vancouver, British Columbia. The Company lists on the OTC Markets.

Minfocus Exploration has a successful management group with a record of numerous discoveries of deposits globally. This includes gold and uranium deposits in Mongolia and PGE-rich resources in the Province of Ontario. In 2015, the Company acquired by option and staking the CORAL zinc property in central British Columbia with historic drilled zones of zinc lead mineralization. In 2017, it acquired by option and staking the Peregrine property in southeastern British Columbia with historic trenched zones of zinc lead, barite mineralization.

Minfocus Exploration holds a 20 percent direct interest in the CORAL Zinc Project. It also has an option to earn up to a 60 percent interest in the project. The CORAL claims have the classic geologic features of the Pine Point style lead-zinc-silver deposits. The CORAL Project is well located for future access and infrastructure.

The Peregrine Zinc Project was acquired by option and staking of claims to encompass a seven kilometer length of carbonate rocks with historical evidence that they host Mississippi Valley Type (MVT) zinc and lead deposits. This property is well located in southeastern British Columbia at relatively low elevations and accessed by old logging roads, 30 kilometers from a major Provincial Highway. Minfocus Exploration can earn 100 percent interest, subject to a 2 percent Net Smelter Return (NSR), in the optioned claim over two years by payment of $10,000 and one million shares.

The Company’s Myst Metals nickel property is positioned within the Blue River ultramafic intrusive complex that extends for approximately 80 kilometers north and northeast of Cassiar, British Columbia. This ultramafic complex has good potential to host “Decar-styled” nickel-iron alloy mineralisation, occurring as the mineral awaruite (Ni3Fe). In 2015, Minfocus Exploration initiated prospecting for nickel and PGE mineralization at the Myst Metals nickel project.

The Company also has its Nipigon Reefs PGE Project. Nipigon Reefs is a large property extending over an area 15 x 20 kilometers, with two focus areas with platinum group elements (PGE), copper and nickel mineralization.

Minfocus Exploration Corp. (MNNFF), closed Friday's trading session at $0.0262, up 223.4568%, on 533 volume with 1 trade. The average volume for the last 3 months is 2,667 and the stock's 52-week low/high is $0.004999999/$0.055100001.

chart

Argentina Lithium & Energy Corp. (PNXLF)

InvestorsHub, Financial Content, The Street, Business Insider, Marketwired, GlobeNewswire, Barchart, Nasdaq, Stockhouse, MarketWatch, Wallet Investor, 4-Traders, Morningstar, and OTC Markets reported earlier on Argentina Lithium & Energy Corp. (PNXLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Argentina Lithium & Energy Corp. focuses on the acquisition and exploration of natural resource properties in Argentina. The Company concentrates on acquiring high quality lithium projects in Argentina and advancing them towards production to meet the growing international demand from the battery sector. A natural resource company and OTCQB-listed, Argentina Lithium & Energy has its corporate office in Vancouver, British Columbia. The Company has its Argentina Exploration Office in Mendoza, Argentina.

Argentina Lithium & Energy has its Antofalla Project. This Project includes greater than14,000 hectares on the Salar de Antofalla in Salta Province, Argentina. This includes a 100 percent interest in roughly 9,000 hectares of mining claims in the north end of the Salar de Antofalla (Staked Properties) and an option agreement to earn a 100 percent interest in three additional properties totaling more than 5,300 hectares (Optioned Properties) positioned adjacent to the Staked Properties.

The Optioned Properties include two granted mine concessions and a third mine application. Terms of the option include cash payments totaling US$3,500,000 over 42 months but limited to only $500,000 in the first 18 months. Moreover, the option includes annual exploration expenditure commitments of $500,000 in year one, followed by $1.5M in year two, $2.0M in year 3, and $3.0M in year 4.

The Company has acquired a 100 percent interest in more than 25,500 hectares covering the Incahuasi Salar and basin in Catamarca province. This salar is within the “Lithium Triangle” of Argentina and Chile. It has characteristics prospective for lithium-rich brines. Initial sampling of near-surface brines returned up to 409mg/L lithium. Geophysical surveying indicates the potential for lithium-rich brines at depth.

Argentina Lithium & Energy is a member of the Grosso Group. The Grosso Group is a resource management group that has pioneered exploration in Argentina since 1993.

At the end of February, Argentina Lithium & Energy announced that Mr. Nick DeMare resigned as a Director the Company. Mr. Nikolaos Cacos, President & Chief Executive Officer of Argentina Lithium & Energy, said, "We want to thank Mr. DeMare for his valuable contributions while serving on the Board." Mr. DeMare has consented to continue serving the Company in an advisory capacity.

Argentina Lithium & Energy Corp. (PNXLF), closed Friday's trading session at $0.0571, up 73.0303%, on 21,000 volume with 4 trades. The average volume for the last 3 months is 4,774 and the stock's 52-week low/high is $0.030999999/$0.0731.

chart

Natcore Technology, Inc. (NTCXF)

Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.

A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.

Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.

Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.

Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.

Recently, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.

The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.

The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.

Natcore Technology, Inc. (NTCXF), closed Friday's trading session at $0.0067, up 91.4286%, on 250 volume with 1 trade. The average volume for the last 3 months is 25,891 and the stock's 52-week low/high is $0.002099999/$0.052099999.

chart

Graphene 3D Lab, Inc. (GPHBF)

OTC Markets, Agora Financial, and Stockhouse reported on Graphene 3D Lab, Inc. (GPHBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Graphene 3D Lab, Inc.,  via its wholly-owned subsidiary, Graphene Laboratories, Inc.,  develops, manufactures, and markets proprietary graphene-based nanocomposite materials for varied kinds of 3D printing. This includes fused filament fabrication. In addition the Company engages in the manufacture and sale of graphene materials and nanocomposite enhanced polymers through Graphene Laboratories.

Recently, Graphene 3D Lab announced that it completed its facility move to the new industrial facility at 760 Koehler Avenue, Ronkonkoma, State of New York. The 8,000 sq. ft. facility is in a tech park close to Long Island MacArthur Airport. It is approximately 30 miles from Graphene 3D Lab’s former Calverton facility.

The Company’s go-to-market product is Conductive Graphene Filament. Conductive Graphene Filament brings users the ability to 3D print circuitry and sensors for electronic applications.  Graphene 3D Lab has its Industrial Materials Division to commercialize graphene composite materials. Graphene is a single-layer of carbon atoms. Graphene is considered a wonder-material for its high strength, conductivity, and ultra-light-weight. 

Furthermore, Graphene 3D Lab  engages in the design, manufacture, and marketing of 3D printers and related products for domestic and  international customers.  It focuses on the development and commercialization of technologies that improve the capabilities of 3D printing.

The Company’s 3D printing division provides a suite of specialty fused fabrication filaments.  In addition,  Graphene 3D Lab owns a new proprietary technology encompassing the preparation and separation of graphene's atomic layers. 

Graphene 3D Lab announced in 2017 the commercial release of two new additions to the G6-Epoxy™ product line of advanced adhesive materials. The product line includes unique carbon-silver adhesive materials. These are built on technology that has undergone development by the Company’s Industrial Division. The new epoxies are highly electrically conductive adhesives with a proprietary formula based on the combination of graphene and silver fillers and other additives. 

Graphene 3D Lab has released the Graphene-HIPS 3D Printing Filament. Graphene-HIPS is a distinctly engineered and innovative semi-flexible FDM 3D Printing material reinforced with graphene. The design of it is for high performance 3D printing. The FDM material exhibits premier interlayer adhesion, toughness, and also premier impact resistance.

In February, Graphene 3D Lab announced it filed a patent application entitled "Method and System for Recovering and Utilizing Heat Energy Produced by Computer Hardware in Blockchain Mining Operations" with the United States Patent and Trademark Office (USPTO). This invention introduces a pioneering new technology for recuperating the thermal energy produced in the computation and Blockchain operation, using that recovered thermal energy in heating and/or refrigeration modules utilizing graphene.

With the method invented by Graphene 3D Lab, the thermal energy produced by the computational hardware is harvested and converted into heating and/or refrigeration solutions with modules utilizing graphene. The solutions can be used for air conditioning or food preservation. Therefore, this lessens electric energy consumption while supporting the Blockchain network or cryptocurrency mining.

Graphene 3D Lab, Inc. (GPHBF), closed Friday's trading session at $0.055, up 83.3333%, on 810,529 volume with 83 trades. The average volume for the last 3 months is 54,009 and the stock's 52-week low/high is $0.016/$0.078000001.

chart

The QualityStocks Company Corner

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

Jerrick Media Holdings’ (OTCQB: JMDA), through its proprietary publishing platform Vocal, is leading the way as more internet users seek a platform to post their original content. Online community sites have come to be the go-to platforms for user-generated content posted online, according to a recent report released by GlobalWebIndex and Reddit (http://nnw.fm/MVks6). To view the full article, visit http://nnw.fm/fi0RT

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Friday's trading session at $2.92, up 12.3077%, on 2,700 volume with 6 trades. The average volume for the last 3 months is 1,072 and the stock's 52-week low/high is $1.63999998/$5.00.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Leading developer of quality assurance software for the commercial 3D printing industry Sigma Labs (NASDAQ: SGLB) this morning announced that it has selected Excel3D Advanced Technologies as its preferred value-added reseller for sales of Sigma Labs products in India. Excel3D Advanced Technologies is a provider of 3D manufacturing software. To view the full press release, visit http://nnw.fm/9Y7Ug. Also today, SGLB announced the availability of a broadcast titled, “Transformative Software Unleashes 3D Printing Industry.” To hear the AudioPressRelease from NetworkNewsAudio, visit: http://nnw.fm/dgG0D
To read the full editorial, visit: http://nnw.fm/Ngl0V

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Friday's trading session at $2.58, up 1.9763%, on 74,974 volume with 395 trades. The average volume for the last 3 months is 88,138 and the stock's 52-week low/high is $1.97000002/$18.50.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

Digital-marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) is strategically positioned to fast-track the growth of its BIGtoken consumer-driven data marketplace after its recent entrance into a secured term loan with an affiliate of B. Riley Financial Inc. Details of the transaction are available in SRAX’s current report on Form 8-K (http://nnw.fm/4mNhq). To view the full article, visit http://nnw.fm/KHzy7

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $2.00, off by 1.4778%, on 41,930 volume with 200 trades. The average volume for the last 3 months is 73,372 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) continues to grow its portfolio as it identifies new opportunities that align with its mission to cultivate the world’s best cannabis and be recognized as a leader in the global industry. To view the full article, visit http://cnw.fm/99VuS. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Marijuana businesses have been left between a rock and a hard place after the federal Small Business Administration (SBA) stated on Monday that marijuana companies aren’t eligible for relief to help cushion them against the Coronavirus pandemic.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.2277, up 12.2394%, on 1,114,549 volume with 479 trades. The average volume for the last 3 months is 563,320 and the stock's 52-week low/high is $0.101000003/$1.72000002.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that senior management will host a conference call on Tuesday, March 31, 2020 at 10 a.m. ET to discuss the Company's fourth quarter 2019 results. VIVO will release its fourth quarter 2019 results on Monday, March 30, 2020, after the close of markets.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.1451, off by 2.748%, on 89,673 volume with 50 trades. The average volume for the last 3 months is 226,664 and the stock's 52-week low/high is $0.109999999/$0.763000011.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media (TSX.V: WNDR) (OTC: WDRFF) on Thursday announced its launch of the "FIRST FILM FUND," a platform for first time film makers to place their films, gain exposure and receive marketing and distribution that will be shown on a dedicated platform. To view the full press release, visit http://nnw.fm/6KvqW.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Friday's trading session at $0.0796, off by 11.5556%, on 60,309 volume with 12 trades. The average volume for the last 3 months is 23,774 and the stock's 52-week low/high is $0.046199999/$0.25999999.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to announce that the Company’s wholly-owned subsidiary, Toronto Herbal Remedies (“THR”) has entered into a cannabis supply agreement with the provinces of Manitoba and Saskatchewan (together, the “Supply Agreements”) through the Manitoba Liquor and Lotteries Corporation and the Saskatchewan Liquor and Gaming Authority, respectively, as at March 27, 2020.. Manitoba and Saskatchewan will be the 3rd and 4th provinces in Canada to carry Sproutly’s CALIBER branded indoor-grown dried flower products ("CALIBER"), following Alberta and New Brunswick in late 2019.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Friday's trading session at $0.0709, off by 2.7435%, on 362,090 volume with 75 trades. The average volume for the last 3 months is 177,082 and the stock's 52-week low/high is $0.052999999/$0.850000023.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Friday's trading session at $1.48, up 0.680272%, on 65,722 volume with 277 trades. The average volume for the last 3 months is 469,716 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Friday's trading session at $0.49, up 104.1667%, on 2,475 volume with 12 trades. The average volume for the last 3 months is 720 and the stock's 52-week low/high is $0.0982/$3.00.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Friday's trading session at $0.20018, up 0.09%, on 92,641 volume with 31 trades. The average volume for the last 3 months is 151,213 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Friday's trading session at $0.0872, up 13.8381%, on 85,000 volume with 5 trades. The average volume for the last 3 months is 43,149 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.0445, up 3.4884%, on 5,452,570 volume with 40 trades. The average volume for the last 3 months is 452,613 and the stock's 52-week low/high is $0.0215/$0.3944.

Recent News

chart

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

The QualityStocks Daily Newsletter would like to spotlight iClick Interactive Asia Group Ltd. (NASDAQ: ICLK).

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider connecting worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping international and domestic marketers reach their target audiences. Headquartered in Hong Kong, iClick operates in 10 locations worldwide, including Asia and Europe.

iClick aims to become a fully integrated Enterprise and Marketing Cloud Platform in China, providing clients a full consumer-cycle solution. This is facilitated by two pillars’ growth strategy through two business segments: Marketing Solutions and Enterprise Solutions.

Marketing Solutions

Using data and AI-driven technology to help brands efficiently identify, target and acquire the right customers

As the leading programmatic marketing platform in China, iClick’s proprietary platform collects a wealth of data from multiple sources to precisely reach the right audience at the right moment, on the right channel and right device. Cross-screen search solutions capture critical micro-moments when users proactively search for what they need. This multi-dimensional approach to marketing allows iClick to effectively understand internet users and exponentially widen target audiences for its brand clients. Multiple monetization models available in the Marketing Solutions segment allow iClick to serve its clients in several ways, such as audience targeting.

Data-driven marketing is indispensable to marketers targeting specific audiences in China. More than 825 million internet users in China are anonymously profiled on iClick’s platform, which boasts cross-channel and cross-screen capabilities.

Enterprise Solutions

Enabling brands to efficiently manage their consumers through online and offline data integration and analysis, increase the repurchase rate, and enhance consumers’ loyalty

iClick’s Enterprise Solutions segment addresses enterprise needs in China, particularly focusing on “smart retail,” an expanding and innovating market involving the combination of online and offline consumers’ behavioral information. Enterprise Solutions support detailed profiling of customers, which facilitates data-driven business strategies, enhances business processes at various levels, and increases operational and marketing efficiency.

Enterprise Solutions leverages iClick’s proprietary platform that incorporates Artificial Intelligence (AI) to learn, build and store knowledge, enabling accurate predictions about consumer behavior that ultimately provide marketing solutions derived from the large amount of available data.

Through a strategic partnership with Tencent, iClick’s Enterprise Solutions presents strong recurring revenue streams with tremendous opportunities to upsell multi-national corporations (MNCs). Tencent’s proprietary API connection enables brands to build 360-degree consumer profiles based on the collection and integration of purchased behavioral information from online and offline touchpoints, including WeChat Mini Programs, WeChat Payment, WeChat Work and more.

As iClick continues to provide integrated marketing and smart retail solutions targeting Chinese consumers, the company believes Enterprise Solutions has strong long-term growth potential and will become a major gross margin contributor in the future.

Partnerships

In 2019, iClick established various agreements and partnerships with a number of leading southeast and northeast Asian companies for regional diversification and in 2020 is focused on continuing to develop additional partnerships and new business models globally. Many of the world’s top companies are leveraging iClick’s proprietary data platform to precisely identify and reach out to core target audience groups in China.

The company’s partnerships include:

  • A tri-partnership with BTG WELINK, an online retail services arm of Beijing Tourism Group (“BTG”), and Tencent Holdings Ltd., China’s leading provider of internet value added services. As part of this partnership, iClick applies its upgraded solutions to build a private DSP (Demand Side Platform) system for BTG. Using Tencent’s big data advertising platform, iClick can assist BTG to develop precision marketing campaigns.
  • An Advertising Agency Authorization Certificate from Baidu Inc. (NASDAQ: BIDU), under which iClick is designated the authorized agency for native advertising of Baidu’s news feed ads. Native advertising is a consumer-friendly, non-disruptive advertising format that has gained rapid popularity among advertisers in recent years. Native advertising and creative marketing content have become a more effective marketing method among the Chinese young consumers. In 2019, the native advertising sector was estimated to have an around 53.5% share of the online advertising revenue, according to Statista.
  • A joint-venture partnership with VGI Global Media Plc (VGI.BKK), Thailand’s No. 1 online to offline (O2O) solutions provider across advertising, payment and logistics platforms, which enables brands in Southeast Asia to capture the multi-billion-dollar Chinese consumer market through a range of technology-driven marketing solutions.

Case Study: Armani Hotel Dubai

Dubai has been gearing up to welcome the growing wave of Chinese visitors. Chinese nationals are eligible for a 30-day visa-on-arrival into the UAE, which gives Chinese travelers tremendous convenience. In light of this, Armani Hotel Dubai set the objective to increase its sales in this market.

The challenge: What Aarmani Hotel Dubai lacked in executing this goal was insightful understanding of Chinese travelers in particular the demographics that were likely to be attracted to the hotel. Challenged by the huge differences in the business practice, unique culture and language barrier in running digital campaigns in China, Armani Hotel Dubai turned to iClick’s know-how and expertise to guide its campaign to success and meet its sales goal.

The solution: iClick tailored an optimal solution for the hotel to increase brand awareness and booking rate from China – which is the key market for the hotel – and successfully assisted Armani Hotel Dubai in reaching its target Chinese audiences by using China’s most popular mobile and internet sites, including WeChat and Weibo, to improve reach and booking potential.

The results: Due to iClick’s unrivaled technological and execution strengths, Armani Hotel Dubai’s ads were delivered in an omnichannel manner, raising brand awareness and garnering interest between Chinese consumers. Subsequently, Armani Hotel Dubai saw a surge in conversion rate.
During the campaign, the Armani Hotel Dubai brand was connected with 87% of Chinese mobile users.

Award-winning Provider

iClick, a Deloitte Technology Fast50, has received multiple industry awards from the international marketing community. The company is committed to helping clients access digital China with its omni-channel, data-driven marketing solutions that deliver uniquely sharpened marketing capabilities and outstanding advertising results.

Most recently, iClick subsidiary OptAim (Beijing) Information Technology Co., Ltd was recognized by Tencent Ads as a 2019 Gold Service Provider. Tencent Ads also named OptAim the winner of three major annual awards for the second half of 2019: “Outstanding Contribution of the Year,” “Best Technology & Data Application Award,” and “Best Branding Awards.”

In November 2019, company co-founder and CEO Sammy Hsieh was chosen as the winner of the “EY Entrepreneur of The Year China 2019 Award in Technology Category,” an award recognizing his entrepreneurial acumen, innovative spirit and strong leadership. As one of the world’s most prestigious business accolades, the “EY Entrepreneur of The Year” awards program honors those who accomplish success by combining ability with opportunity, and inspire others with great vision, leadership and outstanding achievement.

iClick won the Annual Influential Platform Award and the Innovation Golden Award in Marketing at the Creative Award 2019, as well as the Best Tourism Marketing Agency. The company was also the recipient of the “Best Brand and Performance Marketing Award” at the Performance Marketing Ecosystem Summit 2018 hosted by the Advertising & Marketing Service, a division of Tencent Holdings Limited.

The company in 2018 was also recognized as “Platinum Service Partner of Tencent Social Ads” at the Tencent Key Accounts Mid-Year Summit held in Beijing. The mobile division of iClick, Optaim, received the same award beginning in 2016. Optaim was also the “Best DSP Partner” and “Key Account Data Partner” of Tencent, making it the only player in China with such unique and deep level of cooperation with Tencent Social Ads.

Leadership

Sammy Wing Hong Hsieh, chairman of the board and co-founder, was CEO from 2009 to 2019. Prior to co-founding iClick, Hsieh held senior positions in several prominent technology companies. He was general manager for Asia Pacific at Efficient Frontier (now an Adobe company), a leading digital performance marketing company, and was director of Search Marketing at Yahoo Hong Kong from 2000-2008. Hsieh received a bachelor’s degree in economics from the University of California, Los Angeles.

Jian Tang, director, CEO and co-founder, has 20 years of experience in digital advertising and is well-known in China for his expertise in advertising technologies and big data. In 2012, he founded OptAim, which was acquired by iClick in 2015, and has served key research, engineering and management roles at Yahoo’s global research and development center. Tang received his doctorate in computer engineering from Tsinghua University and was named by Campaign Asia as one of the leaders in its Digital A-List in 2016.

Terence Chi Wai Li, chief financial officer, has 15 years of experience in financial management, investment and business operations. He has served in management roles and advisory capacities at several start-ups, in addition to financial management and fundraising roles. He previously worked at PricewaterhouseCoopers, specializing in M&A due diligence and cross border tax and deal structuring projects. Li received an MBA from Oxford University’s Said Business School. He is a Fellow Member of ACCA, a Member of HKICPA, and a Chartered Financial Analyst.

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK), closed Friday's trading session at $4.46, off by 0.668151%, on 218,336 volume with 793 trades. The average volume for the last 3 months is 300,798 and the stock's 52-week low/high is $2.73000001/$5.48999977.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.15, off by 4.0179%, on 9,847 volume with 27 trades. The average volume for the last 3 months is 18,396 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.